Do you want to read an article? Please log in or register.
Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management
Heart, Artery and Coronary Diseases
Related content
RECOMMENDED
Cardiovascular Risk and Diseases
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Eur Heart J
Task Force for the management of COVID-19 of the European Society of Cardiology .
doi: 10.1093/eurheartj/ehab696
RECOMMENDED
Cardiovascular Risk and Diseases
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Eur Heart J
Task Force for the management of COVID-19 of the European Society of Cardiology .
doi: 10.1093/eurheartj/ehab697
Further Publications
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
Circulation.
Hendren NS, Drazner MH, Bozkurt B, Cooper LT Jr
doi: 10.1161/CIRCULATIONAHA.120.047349.
Heart, Artery and Coronary Diseases
ACC/AHA Versus ESC Guidelines for Diagnosis and Management of Peripheral Artery Disease: JACC Guideline Comparison
J Am Coll Cardiol.
Kithcart AP, Beckman JA
doi: 10.1016/j.jacc.2018.09.041.
Further Publications
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military
JAMA Cardiol
Montgomery J, Ryan M, Engler R, Hoffman D, McClenathan B, Collins L, Loran D, Hrncir D, Herring K, Platzer M, Adams N, Sanou A, Cooper LT Jr
doi: 10.1001/jamacardio.2021.2833
Cardiac Arrest or Death
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
Mayo Clin Proc.
Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ
doi: 10.1016/j.mayocp.
Thrombosis and Stroke
COVID-19 Associated Thrombosis and Coagulopathy: Review of the Pathophysiology and Implications for Antithrombotic Management
J Am Heart Assoc
Ortega-Paz L, Capodanno D, Montalescot G, Angiolillo DJ
doi: 10.1161/JAHA.120.019650
Heart Failure
Management of Heart Failure Patients with COVID-19. A Joint Position Paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology
Eur J Heart Fail.
Zhang Y, Stewart Coats AJ, Zheng Z, Adamo M, Ambrosio G, Anker SD, Butler J, Xu D, Mao J, Khan MS, Bai L, Mebazaa A, Ponikowski P, Tang Q, Ruschitzka F, Seferovic P, Tschöpe C, Zhang S, Gao C, Zhou S, Senni M, Zhang J, Metra M
doi: 10.1002/ejhf.1915.
Further Publications
Renin-Angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry
Am Heart J
Núñez-Gil IJ, Olier I, Feltes G, Viana-Llamas MC, Maroun-Eid C, Romero R, Fernández-Rozas I, Uribarri A, Becerra-Muñoz VM, Alfonso-Rodriguez E, García-Aguado M, Elola J, Castro-Mejía A, Pepe M, Garcia-Prieto JF, Gonzalez A, Ugo F, Cerrato E, Bondia E, Raposeiras S, Mendez JLJ, Espejo C, Masjuan ÁL, Marin F, López-Pais J, Abumayyaleh M, Corbi-Pascual M, Liebetrau C, Ramakrisna H, Estrada V, Macaya C, HOPE COVID-19 investigators (Cols appendix).
doi: 10.1016/j.ahj.2021.04.001